Health TrialsbyHealthPanel

Inspiratory and Expiratory Muscle Training in Adolescent Volleyball Players

ConditionAdolescent Development
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age12-18
SponsorGazi University

About this trial

This study will investigate the effects of inspiratory and expiratory muscle training on respiratory muscle strength, pulmonary function, and performance status in adolescent athletes

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Athletes aged 12-18 who train at a submaximal level at least 3 days a week

Disqualifiers

Adolescents with any history of chronic lung disease

unable to comply with the test and training

unwilling to participate in the study

Trial design

Design model

Parallel

Treatments tested in this trial

  • inspiratory muscle training

    Device

    Inspiratory muscle training will be performed

  • expiratory muscle training

    Device

    Expiratory muscle training will be performed

Treatment groups

26 Participants
are divided into 2 treatment groups
Group A: inspiratory muscle training groupExperimental treatment 1 intervention
Group B: expiratory muscle training groupExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Respiratory muscle strength

Maximal inspiratory and expiratory muscle strength will be evaluated using mouth pressure device .

Time frame
First day

Secondary outcomes

1

Constant load-inspiratory muscle endurance test

It will be evaluated with inspiratory muscle trainer

Time frame
First day
2

FEV1

ulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEV1 will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal

Time frame
First day
3

FVC

ulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEV1 will be evaluated. The percentage of predicted value \<70% will be expressed as abnormal

Time frame
First day
4

FEV1/FVC

Pulmonary function tests will be performed using a spirometry according to the American Thoracic Society and European Respratory Society criteria. FEV1/FVC will be evaluated.

Time frame
First day

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Gazi University

Lead sponsor

Amasya University

Sponsor institution

Source ClinicalTrials.gov
Apply now